Park Ogyi, Jeong Won-Il, Wang Lei, Wang Hua, Lian Zhe-Xiong, Gershwin M Eric, Gao Bin
Section on Liver Biology, Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA.
Hepatology. 2009 May;49(5):1683-94. doi: 10.1002/hep.22813.
Liver fibrosis is a common scarring response to all forms of chronic liver injury and is always associated with inflammation that contributes to fibrogenesis. Although a variety of cell populations infiltrate the liver during inflammation, it is generically clear that CD8 T lymphocytes promote while natural killer (NK) cells inhibit liver fibrosis. However, the role of invariant natural killer T (iNKT) cells, which are abundant in the liver, in hepatic fibrogenesis, remains obscure. Here we show that iNKT-deficient mice are more susceptible to carbon tetrachloride (CCl(4))-induced acute liver injury and inflammation. The protective effect of naturally activated iNKT in this model is likely mediated via suppression of the proinflammatory effect of activated hepatic stellate cells. Interestingly, strong activation of iNKT through injection of iNKT activator alpha-galactosylceramide (alpha-GalCer) accelerates CCl(4)-induced acute liver injury and fibrosis. In contrast, chronic CCl(4) administration induces a similar degree of liver injury in iNKT-deficient and wild-type mice, and only a slightly higher grade of liver fibrosis in iNKT-deficient mice than wild-type mice 2 weeks but not 4 weeks after CCl(4) injection, although iNKT cells are able to kill activated stellate cells. An insignificant role of iNKT in chronic liver injury and fibrosis may be attributable to hepatic iNKT cell depletion. Finally, chronic alpha-GalCer treatment had little effect on liver injury and fibrosis, which is attributable to iNKT tolerance after alpha-GalCer injection.
Natural activation of hepatic iNKT cells inhibits, whereas strong activation of iNKT cells by alpha-GalCer accelerates CCl(4)-induced acute liver injury, inflammation, and fibrosis. During chronic liver injury, hepatic iNKT cells are depleted and play a role in inhibiting liver fibrosis in the early stage but not the late stage of fibrosis.
肝纤维化是对各种形式慢性肝损伤的常见瘢痕形成反应,且总是与促成纤维生成的炎症相关。尽管在炎症期间有多种细胞群体浸润肝脏,但一般而言很清楚的是,CD8 T淋巴细胞促进肝纤维化,而自然杀伤(NK)细胞抑制肝纤维化。然而,在肝脏中大量存在的不变自然杀伤T(iNKT)细胞在肝纤维生成中的作用仍不清楚。在此我们表明,iNKT缺陷小鼠对四氯化碳(CCl₄)诱导的急性肝损伤和炎症更易感。在该模型中,自然活化的iNKT的保护作用可能是通过抑制活化的肝星状细胞的促炎作用介导的。有趣的是,通过注射iNKT激活剂α-半乳糖神经酰胺(α-GalCer)强烈激活iNKT会加速CCl₄诱导的急性肝损伤和纤维化。相比之下,慢性给予CCl₄在iNKT缺陷小鼠和野生型小鼠中诱导出相似程度的肝损伤,并且在CCl₄注射后2周而非4周时,iNKT缺陷小鼠的肝纤维化程度仅比野生型小鼠略高,尽管iNKT细胞能够杀伤活化的星状细胞。iNKT在慢性肝损伤和纤维化中的作用不显著可能归因于肝脏iNKT细胞耗竭。最后,慢性α-GalCer治疗对肝损伤和纤维化几乎没有影响,这归因于α-GalCer注射后的iNKT耐受。
肝脏iNKT细胞的自然活化抑制,而α-GalCer对iNKT细胞的强烈激活会加速CCl₄诱导的急性肝损伤、炎症和纤维化。在慢性肝损伤期间,肝脏iNKT细胞耗竭,并且在纤维化的早期而非晚期在抑制肝纤维化中发挥作用。